Cherry Creek Investment Advisors, Inc. Bristol Myers Squibb CO Transaction History
Cherry Creek Investment Advisors, Inc.
- $188 Million
- Q3 2024
A detailed history of Cherry Creek Investment Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cherry Creek Investment Advisors, Inc. holds 10,165 shares of BMY stock, worth $591,907. This represents 0.28% of its overall portfolio holdings.
Number of Shares
10,165
Previous 9,982
1.83%
Holding current value
$591,907
Previous $414,000
27.05%
% of portfolio
0.28%
Previous 0.22%
Shares
14 transactions
Others Institutions Holding BMY
# of Institutions
2,533Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$11 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.24 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.41 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.54 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.55 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $124B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...